SW
Shane Ward
COO & CLO

Shane Ward insider trades: Cidara Therapeutics (CDTX) stock buys and sales

COO & CLO, Cidara Therapeutics Last trade Dec 10, 2025 29 Form 4 filings
$2.2M
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2017
3
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Shane reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 10, 2025CDTX↓ Sell$2.2M
Mar 11, 2025CDTX↓ Sell$37K
Mar 11, 2024CDTX↓ Sell$14K
Mar 13, 2023CDTX↓ Sell$7K
Aug 29, 2019BLCM↑ Buy$10K
Feb 8, 2018VSAR↓ Sell$7K
Oct 19, 2017VSAR↓ Sell$2K
Mar 15, 2017VSAR↓ Sell$39K
Jan 30, 2017VSAR↓ Sell$20K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Shane Ward's insider trades

Shane Ward is COO & CLO at Cidara Therapeutics (CDTX). Since Jan 30, 2017, Shane has reported 1 open-market purchase worth $10K and 8 sales worth $2.3M on SEC Form 4. In the last 12 months: 1 sale ($2.2M).

Their filings also include grants and awards (18 filings), shares withheld for taxes (4 filings), shares returned to the company (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CDTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.